This review aims to investigate the issue of treatment nonadherence and to present the available strategies to improve adherence to oral treatments in breast cancer. A literature search was conducted to contextualise the issue of nonadherence, investigate the reasons behind nonadherence, and demonstrate strategies to address treatment nonadherence in breast cancer. Findings indicate that adherence rates decrease while discontinuation rates increase with increasing lengths of breast cancer treatment course. Lack of adherence is proven to be detrimental to treatment outcomes. Patients struggle to adhere to treatment due to inadequate relationships with healthcare providers, lack of information, psychological distress, and side effects. Healthcare providers should evaluate patient's experience to provide the necessary support. Following this assessment, healthcare providers may recommend interventions addressing patient knowledge, psychological distress or side effects. Treatment adherence remains an issue for oral therapeutics in breast cancer. After patient assessment, healthcare providers can offer personalised strategies to improve treatment adherence. The most crucial interventions address patient knowledge, psychological distress, and side effects.

Cazzaniga, M., Huober, J., Tamma, A., Emde, A., Thoele, K., O'Shaughnessy, J. (2025). Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer. CLINICAL BREAST CANCER, 25(4), 307-324 [10.1016/j.clbc.2024.12.011].

Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer

Cazzaniga M. E.;
2025

Abstract

This review aims to investigate the issue of treatment nonadherence and to present the available strategies to improve adherence to oral treatments in breast cancer. A literature search was conducted to contextualise the issue of nonadherence, investigate the reasons behind nonadherence, and demonstrate strategies to address treatment nonadherence in breast cancer. Findings indicate that adherence rates decrease while discontinuation rates increase with increasing lengths of breast cancer treatment course. Lack of adherence is proven to be detrimental to treatment outcomes. Patients struggle to adhere to treatment due to inadequate relationships with healthcare providers, lack of information, psychological distress, and side effects. Healthcare providers should evaluate patient's experience to provide the necessary support. Following this assessment, healthcare providers may recommend interventions addressing patient knowledge, psychological distress or side effects. Treatment adherence remains an issue for oral therapeutics in breast cancer. After patient assessment, healthcare providers can offer personalised strategies to improve treatment adherence. The most crucial interventions address patient knowledge, psychological distress, and side effects.
Articolo in rivista - Review Essay
Dose adjustement; Interventions; Oral therapies; Treatment adherence; Treatment delay;
English
17-dic-2024
2025
25
4
307
324
open
Cazzaniga, M., Huober, J., Tamma, A., Emde, A., Thoele, K., O'Shaughnessy, J. (2025). Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer. CLINICAL BREAST CANCER, 25(4), 307-324 [10.1016/j.clbc.2024.12.011].
File in questo prodotto:
File Dimensione Formato  
Cazzaniga et al-2025-Clinical Breast Cancer-VoR.pdf

accesso aperto

Descrizione: User License: Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 1.3 MB
Formato Adobe PDF
1.3 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/563984
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact